Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000180275 | SCV000232675 | benign | not specified | 2014-11-25 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001084605 | SCV000288903 | benign | Brugada syndrome 8 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000180275 | SCV000513216 | benign | not specified | 2015-11-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000618904 | SCV000735701 | benign | Cardiovascular phenotype | 2016-08-29 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics Inc | RCV000711886 | SCV000842297 | benign | not provided | 2018-02-06 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003917678 | SCV004729524 | benign | HCN4-related condition | 2019-06-28 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |